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Abstract
Background: This study set out to determine the incidence, socio-demographic, and clinical correlates
of Traditional Eye Medicine (TEM) use in a population of newly presenting ophthalmic outpatients
attending a tertiary eye care centre in south-eastern Nigeria.
Methods: In a comparative cross-sectional survey at the eye clinic of the University of Nigeria Teaching
Hospital (UNTH), Enugu, between August 2004 - July 2006, all newly presenting ophthalmic outpatients
were recruited. Participants' socio-demographic and clinical data and profile of TEM use were obtained
from history and examination of each participant and entered into a pretested questionnaire and
proforma. Participants were subsequently categorized into TEM- users and non-users; intra-group analysis
yielded proportions, frequencies, and percentages while chi-square test was used for inter-group
comparisons at P = 0.01, df = 1.
Results: Of the 2,542 (males, 48.1%; females, 51.9%) participants, 149 (5.9%) (males, 45%; females, 55%)
used TEM for their current eye disease. The TEMs used were chemical substances (57.7%), plant products
(37.7%), and animal products (4.7%). They were more often prescribed by non-traditional (66.4%) than
traditional (36.9%) medicine practitioners. TEMs were used on account of vision loss (58.5%), ocular
itching (25.4%) and eye discharge (3.8%). Reported efficacy from previous users (67.1%) and belief in
potency (28.2%) were the main reasons for using TEM. Civil servants (20.1%), farmers (17.7%), and traders
(14.1%) were the leading users of TEM. TEM use was significantly associated with younger age (p < 0.01),
being married (p < 0.01), rural residence (p < 0.01), ocular anterior segment disease (p < 0.01), delayed
presentation (p < 0.01), low presenting visual acuity (p < 0.01), and co-morbid chronic medical disease (p
< 0.01), but not with gender (p = 0.157), and educational status (p = 0.115).
Conclusion: The incidence of TEM use among new ophthalmic outpatients at UNTH is low. The reasons
for TEM use are amenable to positive change through enhanced delivery of promotive, preventive, and
curative public eye care services. This has implications for eye care planners and implementers. To reverse
the trend, we suggest strengthening of eye care programmes, even distribution of eye care resources,
active collaboration with orthodox eye care providers and traditional medical practitioners, and
intensification of research efforts into the pharmacology of TEMs.
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Background
Worldwide, the last two decades have witnessed a phe-
nomenal increase in the prevalence of use of TEM [1,2].
This is despite that, till date, there is no sound scientific
evidence to justify the use of TEMs in treating eye diseases
[3]. The resort to patronage of TEM has been variously
attributed to ignorance, barriers to access primary eye care
services, preference, failure of conventional treatment,
desire to take control over medical treatment, communi-
cation gap between patients and orthodox eye care pro-
viders, and influence of friends and relations [2,4-7].
Traditional eye medicines (TEMs) are a form of biologi-
cally-based therapies or practices that are instilled or
applied to the eye or administered orally to achieve a
desired ocular therapeutic effect. [3,4]. TEMs are crude or
partially processed organic (plant and animal products)
or in-organic (chemical substances) agents or remedies
that are procured from either a traditional medicine prac-
titioner-TMP (Synonyms: Traditional alternative Medi-
cine Practitioner-TAMP; Traditional Healer-TH, Spiritual
Healer) or non-traditional medicine practitioners which
could be the patient, relation, or friend [1,2].
TEM use, either as sole first line treatment, or as adjunct
used concurrently with conventional therapy has been
associated with poor visual, ocular, and occasionally sur-
vival outcome of otherwise treatable eye diseases in clini-
cal ophthalmic practice [2,8-10].
TEM- related poor ophthalmic treatment outcomes have
been attributed to delay in uptake of eye care services
while on first line TEM therapy; damage to ocular and or
adnexal structures from intrinsic TEM toxicity or result of
interaction with prescribed medications, and microbial
contamination of TEM agent or procedure [2,10-12].
The lack of standardization of dosage, low purity level,
and non-physiologic physico-chemical properties of TEM,
and its unintended role as culture medium for pathogens
account for the observed adverse effects [2,10].
Various epidemiological surveys on TEM have docu-
mented varying prevalence of TEM use, and established
inconsistent associations of TEM use with diverse factors
like age, gender, educational status, rural location of resi-
dence, occupation, socio-economic status, ownership of
health insurance, access to eye care, and time to presenta-
tion for uptake of eye care services [1,5,13-15].
TEM use reflects the diverse eye health care needs of the
population not met by the existing eye care delivery sys-
tem. Consequently, to effectively rein in the tendency to
use TEM, there is the need to understand the health
behaviour, health literacy status, socio-economic varia-
bles, and dimensions of barrier to access eye care in the
population [1,5,15].
In Nigeria's public health sector, promotive, preventive,
and curative orthodox health care delivery is carried out
within the frame work of Primary Health Care. The
healthcare system consists of primary, secondary, and ter-
tiary levels of care which are run by the local, state, and
federal governments respectively. However, there exist an
ample number of privately owned healthcare institutions
that are also involved in the delivery of health services to
the public. In addition, traditional(un-orthodox) medical
practice, although not an officially recognised healthcare
alternative, is flourishing and enjoys patronage from a
broad spectrum of the society. Among Nigerians, cultural
and religious beliefs and practices, especially as they relate
to health, are strong and influence their health seeking
behaviour often in favour of traditional medical care. The
widespread use of traditional medical remedies and prac-
tices for the treatment of common diseases and ailments
has, of recent, prompted the Federal Government, of
Nigeria to initiate and fund research activities to identify
useful traditional herbal medicines [16]. This, hopefully,
would improve the quality of traditional medical services.
This study was intended to determine the incidence,
socio-demographic, and clinical correlates of TEM use in
a clinic population of new ophthalmic outpatients at a ter-
tiary eye care facility in South-Eastern Nigeria.
Methods
The University of Nigeria Teaching Hospital (UNTH),
Enugu, was established in 1971 and is one of the first gen-
eration public tertiary hospitals in Nigeria. The mandate
of the institution includes training, provision of clinical
services, and research. At UNTH, specialist clinical care is
provided on outpatient or inpatient basis; however, there
exists a separate GOPD where patients may initially
present with or without referral letters. Patients presenting
to the GOPD with minor ailments are usually treated as
such and discharged while those requiring specialist care
are referred, as appropriate, to specialist outpatient clinics.
Patients referred with official referral letters, from sources
both within and outside UNTH, present directly to the
specialist outpatient clinics. At the ophthalmic outpatient
clinic, promotive, preventive, curative, and rehabilitative
eye care services are provided by consultant ophthalmol-
ogists, resident ophthalmologists, optometrists, and
nurses.
Questionnaire and proforma development
The instruments used for data collection consisted of a
structured, open-ended, researcher administered ques-
tionnaire and a proforma (Additional file 1). To validateBMC Complementary and Alternative Medicine 2009, 9:40 http://www.biomedcentral.com/1472-6882/9/40
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and ascertain the psychometric reliability of the question-
naire, it was pre-tested on twenty new ophthalmic
patients with or without history of TEM use for the current
eye disease. The proforma, used for recording clinical
examination findings, was similarly pretested. Subse-
quently, observed structural defects in the questionnaire
and proforma, as highlighted by the pre-tests, were cor-
rected before used for the study.
Study population and design
This was a comparative cross-sectional study involving all
newly presenting ophthalmic patients who presented con-
secutively.
Setting
Ophthalmic outpatient clinic of UNTH, Enugu; 1 August
2004 - 31 July 2006. The study questionnaire was used to
collect relevant information on patient's socio-demo-
graphic characteristics, general health status, use of pre-
scribed medicines, and TEM use pattern while the
proforma was used to record their clinical details after
evaluation. Based on reported use of TEM for the current
eye disease episode, the study participants were catego-
rised into two groups: TEM users, and TEM non-users.
For the TEM users, we obtained further information on
the nature, prescriber, reason for use, duration of use, and
route of administration of TEM. Also, we inquired
whether TEM use was on-going at the time of consulta-
tion; for those who had abandoned TEM use, we sought
to know the reason/s for cessation of TEM therapy.
Subsequently, each participant had a comprehensive oph-
thalmic examination including refraction, followed by
relevant clinical and laboratory investigations, where
needed, to arrive at the definitive clinical diagnosis.
During the pretest, we observed that most of the old
patients, especially those with longstanding disease con-
ditions, were unable to recall information relating to pre-
vious TEM use for their current eye disease. Consequently,
to eliminate recall bias, all the old patients were excluded
from the final survey.
Ethical approval
The study was carried out in full compliance with the
1964 Helsinki declaration on research involving human
subjects. The Ethical Committee of UNTH, Enugu,
approved the study. Oral informed consent was obtained
from the participants prior to enrollment into the study.
Data analysis
The data obtained were analysed with the Statistical Pack-
age for Social Sciences (SPSS) software, version 12.0.
Intra-group analyses were performed to yield proportions,
frequencies and percentages.
Inter-group comparisons were also performed to deter-
mine if there were significant differences in the gender,
mean age, marital status, educational status, location of
residence, time to presentation, co-morbid chronic medi-
cal disease, location of ocular pathology, and the best cor-
rected visual acuity at presentation.
Statistical testing for significance of inter-group differ-
ences was performed with Epinfo, version 3.4 at p < 0.01,
df = 1.
Results
Two thousand five hundred and forty two (2,542) new
eye patients consisting of 1,222 (48.0%) males and 1,238
(52.0%) females, aged between 3 months- 72 years (mean
= 56.1 years ± 1.9 SD), were seen at the ophthalmic out-
patient clinic of UNTH, Enugu. Of these, 149 patients
comprising 67(45.0%) males and 82(55.0%) females
aged between 3 months - 68 years (mean = 55.6 years ±
2.3 SD) reported TEM use (TEM users) for treating their
current eye disease.
The incidence of TEM use in the study population was
5.9% (149/2,542).
The remaining 2,393 new patients comprising
1,155(48.3%) males and 1,238(51.7%) females, aged
between 6 months-72 years (mean = 57.2 years ± 2.2SD)
did not use TEM for treating their current ocular disease
and they constituted the TEM non-user Group.
The age and sex distribution of the TEM users is shown in
Table 1.
The nature of TEM used by the patients is presented in
Table 2. Animal products (7, 4.7%), plant prod-
ucts(56,37.7%) and chemical substances (86, 57.7%)
were the groups of TEM used by the patients.
Table 1: Age and sex distribution of TEM users
Sex
Age (yrs) M F Total (%)
0 -- 10 4 3 7(4.7)
11-20 13 12 25(16.8)
21-30 10 12 22(14.8)
31-40 7 10 17(12.4)
41-50 6 12 18(12.1)
51-60 7 13 20(13.4)
61-70 20 20 40(26.8)
Total (%) 67(45%) 82(55%) 149(100%)BMC Complementary and Alternative Medicine 2009, 9:40 http://www.biomedcentral.com/1472-6882/9/40
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The profile of TEM use is summarized in Table 3.
TEM users
The TEM users were either married (42, 51.7%) or single
(40, 48.3%).
Their occupations included civil service (30, 20.1%),
farming (26, 17.7%), and trading (21, 14.1%).
Majority (115, 77.0%) of these patients had at least a for-
mal primary education and reside in an urban area-
92(62.0%). Diminution of vision (87, 58.5%), ocular
itching (38, 25.4%), and eye discharge (3,3.8%) were the
leading presenting complaints in the sub-group.
TEM users tended to present later than one month (131,
87.9%) after onset of their ocular complaint, which were
mainly due to ocular anterior segment disease (108,
72.5%).
At presentation, majority (n = 120, 80.5%) of TEM users
had stopped the use of TEM. Of these, unsatisfactory
response to TEM therapy (71, 59.1%), worsening of eye
condition (40, 33.3%), and advice from others (6, 5.0%)
were the main reasons for abandonment of TEM use. Of
the TEM users, 34(23.0%) were blind (best corrected dis-
tant visual acuity less than 3/60 in the better eye) at pres-
entation.
TEM non-users
The TEM non-users were either married (1,393, 58.2%) or
single (1,000, 42.8%). Their occupations included civil
service (473, 19.8%), farming (325, 13.6%) and trading
(306, 12.8%). majority-1,603(67.0%) of the participants
had a minimum of primary education while
2,105(88.0%) reside in an urban area.
Diminution of vision (1,220, 51.0%), ocular itching (675,
28.2%), and eye discharge (200, 8.4%) were the leading
presenting complaints in this group.
TEM non-users tended to present within one month
(1,316, 55.0%) of onset of their ocular complaints which
were mainly due to anterior segment disease
(1,484,62.0%).
The chronic diseases seen in the participants were sys-
temic hypertension [(217, 8.5%): TEM users (24.8%),
TEM non-users(7.5%), diabetes mellitus [(76, 3.0%):
TEM users(13.4%), TEM non-users (2.4%)], and HIV/
AIDS [(18,0.7%): TEM user(2.0%), TEM non-
users(0.7%)] At presentation, 860(33.8%) patients com-
prising of TEM users (78, 52.3%) and TEM non-users
(782,32.7%)were on prescribed medicines. The pre-
scribed medicines were administered by direct application
into the eye [TEM users (50, 33.6%), TEM non-users (332,
Table 2: Nature of TEM used
TEM n(%)
Animal products
Human urine 4(2.7)
Human breast milk 2(1.30
Cod liver oil 1(0.7)
Plant products
Herbal extract 42(28.2)
Aloe vera product 10(6.7)
Palm wine 2(1.3)
Palm oil 1(0.7)
Bitter kola extract 1(0.7)
Chemical substances
Holy water 56(37.6)
Anointed oil/Olive oil 13(8.7)
Black stone 4(2.7)
Natural (spring) water 3(2.0)
Powder 2(1.30)
Salt solution 2(1.3)
Sugar solution 2(1.3)
Forever living product 1(0.7)
Antimony 1(0.7)
Kerosene 1(0.7)
*Harcogen rub 1(0.7)
Total 149(100.0)
*Mentholated rub
Table 3: Nature of TEM used
Characteristic n (%)
TEM prescriber
Traditional medicine practitioner
Traditional Healer 33(22.1)
Clergyman (spiritual healer) 22(14.8)
Non-traditional medicine practitioner
Patient 42(28.2)
Friend 30(20.1)
Relation 17(11.4)
Not specified 5(3.4)
Duration of use (weeks)
≤ 1 58(39.0)
2-8 40(26.8)
9-24 24(16.1)
25-52 6(4.0)
> 52 21(14.1)
Reason for use
Others benefited 100(67.1)
Belief in potency 42(28.2)
Orthodox medicine un-affordable 3(2.0)
Unaware of orthodox alternatives 2(1.3)
Unsatisfactory orthodox treatment 2(1.3)
Route of administration
Instillation 126(84.6)
Oral 17(11.4)
Face wash 4(2.7)
Inhalation 2(1.3)BMC Complementary and Alternative Medicine 2009, 9:40 http://www.biomedcentral.com/1472-6882/9/40
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13.8%)] and orally [TEM users (50, 33.6%), TEM non-
users (332, 13.8%)].
Inter- Group comparisons showed significant inter- group
differences in mean age (55.6 ± 2.3 SD vs 57.2 ± 2.2 SD, p
< 0.01), marital status (52.0% vs 32.0%, p < 0.01), resi-
dence (urban: 62% vs 91%, p < 0.01), time to presenta-
tion ≤1 month (88.0% vs 45.0%, p < 0.01), co-morbid
chronic medical disease (24.8% vs 7.5%, p < 0.01), ocular
anterior segment location of pathology (73.0% vs 22.0%,
p < 0.01), and those with presenting visual acuity less than
3/60 (15% vs 3%, p < 0.01).
However, there was no significant inter-group difference
in the proportion of female patients (55.0% vs 45.0%, p =
0.157), and educational status (77.0% vs 67.0%, p =
0.115).
Discussion
Previous studies that have evaluated TEM use for eye dis-
eases have reported various prevalence rates[1,2,11,3-15]
but we have evaluated incidence of TEM use since our
focus was on newly presenting ophthalmic patients. Since
there was no previous report on the incidence of TEM use
for eye diseases, we were constrained to compare inci-
dence from our study with previously reported preva-
lence.
The 5.9% incidence of TEM use observed in this study is
small when compared with 47.7% reported in India [1],
17.9% in Democratic Republic of Congo (DRC) [11],
33.8% in Malawi [13], 62.3% in Oman, and 49.0% in
Tanzania [15]. The rate was however higher than 1.72%
previously reported in Nigeria [2]. The variations in the
rates may be attributed to the differences in the study set-
tings, populations, and the specific use of TEM for the eye
diseases. While the present study involved all newly pre-
senting ophthalmic outpatients to a tertiary eye care cen-
tre, irrespective of the eye diseases, previous studies
[1,13,14] investigated TEM use specifically in ophthalmic
patients who presented with corneal ulcer. Others based
their studies on a general population of ophthalmic
patients [11] or specifically evaluated TEM use for ocular
trauma [15]. A study previously done in Nigeria [2] was in
a setting similar to ours but involved both old and new
patients; thus while we reported incidence of TEM use, the
study reported prevalence of TEM use. Furthermore, cor-
neal ulceration and ocular trauma have been established
to be associated with the likelihood of TEM therapy
[11,13]. This might further explain the comparatively
higher prevalence figures reported from studies on TEM
use in corneal ulcer and ocular trauma patients.
The socio-demographic characteristics of the study partic-
ipants revealed that those who presented with ocular
complaints were predominantly in the productive age
group. The majority of TEM users were aged forty years or
older; however, their mean age was significantly less than
that of non-users; there were more females than males in
the TEM user Group, however, there was no statistically
significant inter-group difference in the proportion of
females. The age and gender distribution observed in this
survey is similar to the observations in USA [5] but dif-
fered from the findings in India [1], Malawi [13] and the
DRC [11]. Resort to TEM use by females and the aged has
been attributed to gender and age related barriers to access
eye care services [5]. This seems to suggest that promotive
and preventive eye care activities aimed at discouraging
TEM use must have them as prime targets. The high inci-
dence of eye diseases observed in the productive age group
has adverse economic implications for the patient, the
family, and the country. The economic costs of the result-
ing visual loss, in this productive age group, arise from
direct job losses suffered by the patients, cost of treatment,
rehabilitation, and employing care giver for the irreversi-
bly blind [17,18]. The married participants and those
residing in rural areas were observed to have a signifi-
cantly higher likelihood to use TEM than their single and
urban counterparts. This is consistent with the findings of
previous studies done in Nigeria [2,8]. The influence of
marriage probably reflects the role of family members as
major prescribers of TEM after traditional medical practi-
tioners [11,19,20]. Rural residence imposes both geo-
graphic and economic barriers to access eye care services,
which at present, in Nigeria, are concentrated in urban
areas; this leaves the rural dwellers with no other alterna-
tive eye care provider except the traditional medical prac-
titioners who reside with them in the rural areas [2,8,21].
The higher tendency to use TEM among rural dwellers,
which this study has established, implies either rural non-
availability or reduced uptake of available promotive and
preventive eye care services in the rural areas. This survey
did not show any significant association between educa-
tional status and TEM use. This is at variance with the find-
ings of in Malawi [11]; however, the difference in the
study populations between the two surveys might explain
the apparent discrepancy. By implication, health educa-
tion and health awareness creation programmes, rather
than provision of traditional western education, impact
more on TEM use and are therefore imperative for creating
a positive change in this direction.
The profile of TEM use in this study showed that more of
plant products and chemical substances than animal
products were used as TEMs. This is consistent with the
reports in India [1] and elsewhere [22], and in keeping
with the general trend that, in Africa, TEMs are more of
plant than animal origin [1]. In addition to traditional
African trend, the study area, South-eastern Nigeria, has of
late witnessed massive proliferation of spiritual churchesBMC Complementary and Alternative Medicine 2009, 9:40 http://www.biomedcentral.com/1472-6882/9/40
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(prayer houses), where spiritual healers prescribe partially
processed plant products, holy water, and olive oil as
pharmacologic adjuncts to their spiritual therapy for eye
diseases. The majority (59.7%) of the TEM users obtained
their prescriptions from non-traditional practitioners who
were patients themselves, friends or relations. This trend
in prescription pattern of TEM is similar to observation in
Malawi [11] (non-traditional medical practitioner -
72.6%, traditional medical practitioner-27.4%)[11]. This
implies that, although the traditional medical practitioner
is the originator of TEM therapy, societal input plays a cru-
cial role in the perpetuation of the practice. Reported ther-
apeutic benefit from other TEM users and patients' belief
in the potency of TEM contributed more to the decision to
use TEM than cost and awareness barriers to access ortho-
dox eye care. Contrarily, preference and proximity [11],
and absence of side effects and low cost [8], have been
previously reported as overriding reasons for using TEM.
The scenario spotlights a potential point for intervention
in future planning of the eye health literacy needs of the
society necessary to curtail the use of TEM. Although the
present survey did not document any adverse effect of
TEM, their use may constitute a great hazard to the eye
even though there are probably some definite therapeutic
benefits inherent in their use [23-27]. This suggests that
products used as TEM should be subjected to analytical
research to isolate, purify, and characterize their active
contents for possible use in allopathic medicine. At pres-
entation, 65.8% of TEM users had been on the treatment
for eight weeks or less; the treatment modality was mainly
direct instillation into the conjunctival sac (84.6%), and
80.5% had abandoned the treatment due to lack of
improvement or worsening of eye condition. However,
these figures have to be interpreted against the back-
ground that 40.0% of TEM users either do not disclose it
at all or withhold relevant information relating to its use
[10]. That recognized, the duration of therapy, and its
abandonment or otherwise, reported by TEM users, in this
study, might not have reflected the true situation.
Furthermore, although not reported by any participant,
adverse reactions resulting primarily from TEM or from its
interaction with prescribed medicines could have contrib-
uted to the high abandonment rate. This is corroborated
by reported adverse effects of complementary and alterna-
tive medicine and their interaction with prescribed medi-
cines [3,5,10].
The clinical profile of the study population revealed that
the pattern of presenting complaint did not differ between
TEM users and non-users, however, those who reported
TEM use presented later, had more of ocular anterior seg-
ment pathology, and lower entry distant visual acuity.
Late presentation and low presenting visual acuity among
TEM users, apparently due to delays caused by prior TEM
use, have been variously reported [3,7,11-14]. The spec-
trum of presenting complaints necessitating presentation
in the present survey differed from the series reported in
Malawi [11], who had trauma/posterior segment disease
topmost, probably due to differences, between the two
surveys in survey population and study settings. This sug-
gests that the necessary human and material resources,
needed for the treatment of these leading eye conditions,
should be made available and accessible to all by planners
and implementers of eye care programmes. In this survey,
TEM use was significantly associated with co-morbid
chronic systemic medical disease. The use of complemen-
tary and alternative medicines, similar to TEM, for chronic
medical diseases has been reported in children [28] and
adults [29]. Perhaps, this may explain the high rate of
TEM use among our patients with co-morbid chronic sys-
temic medical diseases. The prevalence of TEM use is a
better way of knowing the total population of ophthalmic
patients using TEM, unfortunately, we have evaluated
only the incidence of TEM use since our focus was on
newly presenting ophthalmic patients only. Thus our
study was biased towards underestimating TEM use.
The tendency for TEM users to conceal the fact of TEM use
or information relating to it, probably to avoid social stig-
matisation, could have lead to further underestimation of
incidence of TEM use, or affected the reported roles of its
correlates.
Conclusion
The incidence of TEM use among new ophthalmic outpa-
tients at the University of Nigeria Teaching Hospital,
Enugu, is low. Chemical substances and plant products
rather than animal products were more frequently used as
TEM. Non-traditional medicine practitioners were the
main prescribers of these TEMs. To reverse the trend, the
authors suggest strengthening of promotive and preven-
tive eye care programmes, even distribution of eye care
resources, active and continuous collaboration with tradi-
tional medical practitioners, and intensification of phar-
macological research efforts, to establish the efficacy or
otherwise, of the of the "supposedly potent" TEMs.
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